Inotek

Inotek Pharmaceuticals is a biotech company which recently started enrolling patients for its phase II trial for its compound IND-001, for the prevention of cardiac necrosis. INO-1001 is a potent inhibitor of PARP.

It is based at Beverly, Massachusetts.